Pancreatic Cancer Research

ResearcherThe University of TokyoActive in the last 2 years

Takahiro Kishikawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8602-5916; OpenAlex author ID A5024035957. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 1 paper

Papers 14

  1. Association between Serum Human Satellite II RNA and miR-21-5p Levels and Time to Pancreatic Cancer Diagnosis in a Prospective Population-based Study. Co-author DOI 10.1097/mpa.0000000000002723↗
  2. WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway. First author DOI 10.1007/s00535-024-02192-x↗
  3. Blockade of CC chemokine receptor 2 suppresses pancreatic cancer progression through the interaction with macrophages in the tumor microenvironment. Co-author DOI 10.1038/s41598-025-32222-4↗
  4. CA19-9-Positive Extracellular Vesicle Is a Risk Factor for Cancer-Associated Thrombosis in Pancreatic Cancer. Co-author DOI 10.1016/j.gastha.2024.02.005↗
  5. Satellite double-stranded RNA induces mesenchymal transition in pancreatic cancer by regulating alternative splicing. First author DOI 10.1016/j.jbc.2024.105742↗
  6. Combination of serum human satellite RNA and miR-21-5p levels as a biomarker for pancreatic cancer. Co-author DOI 10.1016/j.isci.2023.106021↗
  7. Lipolysis by pancreatic cancer-derived extracellular vesicles in cancer-associated cachexia via specific integrins. Co-author DOI 10.1002/ctm2.1089↗
  8. Smaller extracellular vesicles are released from pancreatic cancer cells by the alteration of the lipid composition under low glucose conditions. Co-author DOI 10.1016/j.bbrc.2022.11.040↗
  9. The biological role of metabolic reprogramming in pancreatic cancer. Co-author DOI 10.1002/mco2.37↗
  10. A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer. Co-author DOI 10.1007/s10637-018-0691-9↗
  11. Satellite RNA Increases DNA Damage and Accelerates Tumor Formation in Mouse Models of Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-18-0139↗
  12. Quantitation of circulating satellite RNAs in pancreatic cancer patients. Co-author DOI 10.1172/jci.insight.86646↗
  13. [IPMN and pancreatic cyst as high risk of pancreatic cancer]. Co-author DOI 10.11405/nisshoshi.112.1474↗
  14. Circulating RNAs as new biomarkers for detecting pancreatic cancer. Co-author DOI 10.3748/wjg.v21.i28.8527↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Motoyuki Otsuka · 10 shared papers, 2016–2026 · strength 1.71
  2. Takahiro Seimiya · 9 shared papers, 2018–2026 · strength 1.65
  3. Mitsuhiro Fujishiro · 7 shared papers, 2022–2026 · strength 1.56
  4. Chikako Shibata · 6 shared papers, 2022–2026 · strength 1.20
  5. Genso Notoya · 4 shared papers, 2024–2026 · strength 0.94
  6. Kazunaga Ishigaki · 6 shared papers, 2015–2024 · strength 0.87
  7. Hideaki Ijichi · 5 shared papers, 2015–2025 · strength 0.76
  8. Kazuhiko Koike · 7 shared papers, 2015–2024 · strength 0.71
  9. Takuma Iwata · 4 shared papers, 2020–2025 · strength 0.70
  10. Koji Miyabayashi · 3 shared papers, 2015–2025 · strength 0.54
  11. Tatsunori Suzuki · 4 shared papers, 2018–2024 · strength 0.54
  12. Yousuke Nakai · 4 shared papers, 2015–2026 · strength 0.51
  13. Keisuke Yamamoto · 3 shared papers, 2015–2025 · strength 0.33
  14. Makoto Sano · 1 shared paper, 2025 · strength 0.27
  15. Gen Kimura · 1 shared paper, 2025 · strength 0.27
  16. Keitaro Matsuo · 1 shared paper, 2026 · strength 0.26
  17. Ryota Takahashi · 1 shared paper, 2025 · strength 0.24
  18. Hiroki Oyama · 1 shared paper, 2023 · strength 0.14
  19. Minoru Tada · 2 shared papers, 2015–2019 · strength 0.11
  20. Tomotaka Saito · 2 shared papers, 2015–2019 · strength 0.11
  21. Suguru Mizuno · 2 shared papers, 2015–2019 · strength 0.11
  22. Saburo Matsubara · 2 shared papers, 2015–2019 · strength 0.11
  23. Tsuyoshi Takeda · 2 shared papers, 2015–2019 · strength 0.11
  24. Naminatsu Takahara · 2 shared papers, 2015–2019 · strength 0.11
  25. Hirofumi Kogure · 2 shared papers, 2015–2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.